Cart
sales@molnova.com
EML4-ALK kinase inhibitor 1
CAS No. 1373409-08-5
EML4-ALK kinase inhibitor 1( EML4 ALK kinase inhibitor 1 )
Catalog No. M26196 CAS No. 1373409-08-5
EML4-ALK kinase inhibitor 1 is a potent oral active inhibitor of echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK), with an IC50 of 1 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 271 | In Stock |
|
| 5MG | 212 | In Stock |
|
| 10MG | 316 | In Stock |
|
| 25MG | 510 | In Stock |
|
| 50MG | 681 | In Stock |
|
| 100MG | 921 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1832 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEML4-ALK kinase inhibitor 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionEML4-ALK kinase inhibitor 1 is a potent oral active inhibitor of echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK), with an IC50 of 1 nM.
-
DescriptionEML4-ALK kinase inhibitor 1 is a potent oral active inhibitor of echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK), with an IC50 of 1 nM.
-
In Vitro——
-
In Vivo——
-
SynonymsEML4 ALK kinase inhibitor 1
-
PathwayOthers
-
TargetOther Targets
-
RecptorLp-PLA2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1373409-08-5
-
Formula Weight580.778
-
Molecular FormulaC31H48N8O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 110 mg/mL (189.41 mM)
-
SMILESCCc1nc(C(N)=O)c(Nc2ccc(N3CCC(CC3)N3CCN(C)CC3)c(OC)c2)nc1N[C@H]1CC[C@@H](CC1)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zehong Wan, et al. Bicyclic pyrimidone compounds. WO2013014185A1.
molnova catalog
related products
-
loddigesiinol A
loddigesiinol A
-
MTIC
MTIC is the active metabolite of Temozolomide (TMZ) with anticancer and antitumor activity and is used in the study of melanoma.3'-Sialyllactose (3'-SL) sodium is a prebiotic with anti-inflammatory activity.
-
Dynorphin A (1-8)
Dynorphin A (1-8) is the predominant opioid peptide identified in placental tissue extracts. Dynorphin A (1-8) is the most likely natural ligand of the kappa receptor. The binding of 3H-Bremazocine to the purified kappa receptor is inhibited by Dynorphin A (1-8) (IC50=303 nM).
